BME Issues Certificate of Waiver to Carry Out Overdose Prevention Act
The Overdose Prevention Act, which is meant to reduce overdose related deaths by encouraging victims and witnesses of overdose to obtain medical care without criminal or civil liability, supports distribution of Naloxone to those considered at risk for opioid overdose, as well as to their friends, family, or first responders. The Act allows physicians to prescribe Naloxone with civil, criminal, and professional disciplinary immunity.
The NJ Board of Medical Examiners (BME) recently approved a regulatory proposal that explains physician rights and responsibilities under the Act. The BME issued a Certificate of Waiver to all licensed physicians in order to expedite operation of the Act, while the proposed rules are promulgated. The waiver explains that physicians may issue Naloxone prescriptions to family, friends, or first responders without requiring examination or follow-up of the at risk individual.